Overview

Apoptosis Assays Market Introduction:

Apoptosis assays market is anticipated to value around USD 7.5 billion by 2027 end and register a CAGR of over 9.7% from the forecast period 2020-2027.

The mounting funds assigned for cancer research coupled with innovations on apoptosis assays drugs are the driving factors expanding the market. Additionally, increased cell-based research along with rising cases of infectious diseases is positively influencing the market.
The market is bifurcated into by product, by detection technology, by application, by end-user and region. In terms of product, assay kits are expected to dominate the growth of the market.
The ability of assay kits to detect nuclear changes coupled with the adoption of assay kits in multiple procedures like environmental monitoring, life science research is stimulating the market. It is also used in the screening of drug candidates, evaluating biopharmaceutical production processes and studying diseases. Owing to these features, assay kits are expected to hold a majority share of the market.
In terms of detection technology, cell imaging and microscopy are forecasted to witness notable growth owing to the increasing preference towards cell imaging and microscopy in drug discovery applications, basic research, and diagnostic laboratories.
Based on application, drug discovery and development holds a vast share of the market. The increasing prevalence and incidence of infectious and chronic diseases are driving the demand for drug discovery and development. The increasing research and development activities coupled with mounting government efforts taken to develop new treatments for multiple diseases is expanding the apoptosis synthesis market size.

North America is the global leader of the market. Increasing incidences of chronic diseases and soaring investments for cancer research is fueling the market growth in the region. Furthermore, soaring research and development activities alongside favourable government policies in the region are boosting the market presence in the region.

Asia-Pacific region is expected to be a lucrative region owing to increased spending on the healthcare sector and the presence of a larger patient population. Moreover, the presence of a large number of local players coupled with increasing cases of infectious diseases is positively influencing the market in the region.

Prominent players of the market are:
Danaher Corporation, BioTek Instruments, Promega Corporation, PerkinElmer, Abcam plc, Abnova, Creative Bioarray, Thermo Fisher Scientific, Merck KgaA, Becton, GE Healthcare, Dickinson and Company, Geno Technology GeneCopoeia, Inc and Sartorius.

Competitive Landscape:

Merck acquired Sigma Aldrich Corporation. The move helped Merck to strengthen its life science segment
Thermo Fisher Scientific in 2018, launched Multiskan Sky Microplate Spectrophotometer
Dickinson and Company and Becton in 2017 acquired C.R Bard
GE Healthcare Life Sciences opened its new manufacturing site in Austria in 2018. The move will help the company strengthen its product supply all over Europe

Apoptosis Assays Market Segmentation:

By Product

Assay Kits
Caspase Assays
Annexin V and Cell Permeability Assays
DNA Fragmentation Assay
Mitochondrial Assays
Microplates
Instruments
Reagents

By Detection Technology
● Flow Cytometry
● Cell Imaging & Analysis Systems
● Spectrophotometry
● Other Detection Technologies

By Application
● Basic Research
● Clinical & Diagnostic Applications
● Drug Discovery & Development
● Stem Cell Research

By End User
● Hospital and Diagnostic Laboratories
● Pharmaceutical and Biotechnology Companies
● Academic and Research Institutes

By Region
● North America
● Europe
● Asia Pacific
● Latin America
● Rest of the World

FutureWise Key Takeaways
● Growth Prospects
● SWOT Analysis
● Key Trends
● Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the apoptosis market by product, by detection technology, by application, by end-user and by region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• Evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America and the rest of the world
• To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
• Profiling of companies to evaluate their market shares, strategies, financial and core competencies

Flexible Delivery Model:

We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
The customization Mobility Care offered are free of charge with purchase of any license of the report
You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com